Medistim ASA (FRA:MD1)

Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of EUR 402.23 million. The enterprise value is 390.64 million.

Market Cap	402.23M
Enterprise Value	390.64M

Important Dates

The next estimated earnings date is Thursday, April 9, 2026.

Earnings Date	Apr 9, 2026
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	18.28M
Shares Outstanding	n/a
Shares Change (YoY)	-0.17%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	2.94%
Owned by Institutions (%)	85.96%
Float	12.62M

Valuation Ratios

The trailing PE ratio is 33.10 and the forward PE ratio is 29.18.

PE Ratio	33.10
Forward PE	29.18
PS Ratio	7.12
PB Ratio	11.26
P/TBV Ratio	13.91
P/FCF Ratio	25.49
P/OCF Ratio	24.68
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.72, with an EV/FCF ratio of 24.75.

EV / Earnings	32.14
EV / Sales	6.95
EV / EBITDA	22.72
EV / EBIT	25.59
EV / FCF	24.75

Financial Position

The company has a current ratio of 3.33, with a Debt / Equity ratio of 0.05.

Current Ratio	3.33
Quick Ratio	2.03
Debt / Equity	0.05
Debt / EBITDA	0.11
Debt / FCF	0.12
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 34.58% and return on invested capital (ROIC) is 26.35%.

Return on Equity (ROE)	34.58%
Return on Assets (ROA)	21.07%
Return on Invested Capital (ROIC)	26.35%
Return on Capital Employed (ROCE)	40.19%
Revenue Per Employee	366,916
Profits Per Employee	78,917
Employee Count	154
Asset Turnover	1.24
Inventory Turnover	0.77

Taxes

In the past 12 months, Medistim ASA has paid 3.83 million in taxes.

Income Tax	3.83M
Effective Tax Rate	23.96%

Stock Price Statistics

The stock price has increased by +64.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+64.06%
50-Day Moving Average	20.62
200-Day Moving Average	18.05
Relative Strength Index (RSI)	55.98
Average Volume (20 Days)	70

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of EUR 56.51 million and earned 12.15 million in profits. Earnings per share was 0.66.

Revenue	56.51M
Gross Profit	45.78M
Operating Income	15.34M
Pretax Income	15.98M
Net Income	12.15M
EBITDA	16.52M
EBIT	15.34M
Earnings Per Share (EPS)	0.66

Balance Sheet

The company has 13.45 million in cash and 1.82 million in debt, giving a net cash position of 11.64 million.

Cash & Cash Equivalents	13.45M
Total Debt	1.82M
Net Cash	11.64M
Net Cash Per Share	n/a
Equity (Book Value)	35.72M
Book Value Per Share	1.95
Working Capital	25.46M

Cash Flow

In the last 12 months, operating cash flow was 16.30 million and capital expenditures -517,796, giving a free cash flow of 15.78 million.

Operating Cash Flow	16.30M
Capital Expenditures	-517,796
Free Cash Flow	15.78M
FCF Per Share	n/a

Margins

Gross margin is 81.03%, with operating and profit margins of 27.14% and 21.51%.

Gross Margin	81.03%
Operating Margin	27.14%
Pretax Margin	28.29%
Profit Margin	21.51%
EBITDA Margin	29.24%
EBIT Margin	27.14%
FCF Margin	27.93%

Dividends & Yields

This stock pays an annual dividend of 0.51, which amounts to a dividend yield of 2.44%.

Dividend Per Share	0.51
Dividend Yield	2.44%
Dividend Growth (YoY)	33.88%
Years of Dividend Growth	n/a
Payout Ratio	76.86%
Buyback Yield	0.17%
Shareholder Yield	2.61%
Earnings Yield	3.02%
FCF Yield	3.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6